28.04.2011 • News

Merck & Co to Buy Back Up To $5 Billion Of Its Shares

Merck & Co said on Wednesday it plans to buy back up to $5 billion in shares, bringing its total share buyback program to $6.4 billion.
The Whitehouse Station, New Jersey-based drugmaker said the stock purchase has no time limit and will be made on the open market, in block transactions or privately negotiated transactions.

"Merck has a history of leadership in returning cash to shareholders," said Kenneth Frazier, Merck's chief executive officer. "Today's action reflects our confidence in Merck's strategy and demonstrates our commitment to delivering shareholder value."

The company still has $1.4 billion remaining from a share repurchase authorization announced in November 2009.

Company

Logo:

Merck & Co

126 East Lincoln Avenue
07065 Rahway
US

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read